Cyclic AMP-dependent Cl- secretion induced by thromboxane A2 in isolated human colon

Area of Science:

• Gastroenterology
• Molecular Pharmacology
• Cell Physiology

Background:

• Increased thromboxane A(2) (TXA(2)) release is implicated in inflammatory bowel diseases.
• The precise mechanisms of TXA(2) action in colonic inflammation require further elucidation.

Purpose of the Study:

• To investigate the effects of a stable TXA(2) analogue (STA(2)) on human colonic mucosa electrical parameters.
• To identify the signaling pathways involved in STA(2)-induced chloride secretion.

Main Methods:

• Isolated human colonic mucosa mounted in Ussing chambers.
• Concentration-dependent stimulation with STA(2) and measurement of chloride secretion.
• Inhibition studies using a TXA(2) receptor antagonist (ONO-3708) and a KvLQT1 channel inhibitor (Chromanol 293B).
• Analysis of KvLQT1 mRNA and protein expression.
• Measurement of intracellular cyclic AMP (cAMP) levels and short-circuit current in a human colonic cell line.

Main Results:

• STA(2) stimulated chloride secretion in a concentration-dependent manner (EC(50) = 0.06 µM).
• STA(2)-induced secretion was inhibited by a TXA(2) receptor antagonist and a cAMP antagonist.
• KvLQT1 channel inhibition attenuated the response, and KvLQT1 was expressed throughout the colon.
• STA(2) increased intracellular cAMP levels and short-circuit current in a human colonic cell line.

Conclusions:

• TXA(2)-induced chloride secretion in the human colon is mediated by the cAMP pathway.
• This mechanism involves the KvLQT1 channel.
• Findings suggest TXA(2) and its signaling pathways as potential therapeutic targets for inflammatory bowel diseases.